Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion

Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion

Background Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first‐line antiplatelet treatment in acute coronary syndrome. We sought to assess the prognostic impact of high pl...

Full description

Bibliographic Details
Main Authors: Maria Grazia De Gregorio, Rossella Marcucci, Angela Migliorini, Anna Maria Gori, Betti Giusti, Ruben Vergara, Rita Paniccia, Nazario Carrabba, Niccolò Marchionni, Renato Valenti
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
antiplatelet therapy
chronic total occlusion
platelet reactivity
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014676

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014676

Similar Items